[Immunological mechanism of human alpha-interferon gene therapy for treatment of melonoma].
To investigate the possibility of alpha-INF gene therapy for treatment of melonoma. An experimental model of fibroblast-mediated human alpha-IFN gene therapy was established for treatment of melonoma and the activity of NK and M phi was determined. The NK and M phi activity was increasing significantly after the implantation of alpha-IFN secreted by cloning the fibroblast in vivo. Good therapeutic results could be achived if the NIH3T3-IFN-alpha+ cells were combined with the IL-2/AK. The results has indicated that the fibroblast-mediated gene therapy could be good to use it for the treatment of human melonoma. More effective results could be achieved by using it in combination with IL-2.